Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
tofisopam | camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | small molecule | NA | drugbank | Anxiety Disorders[MeSHID:D001008] Anxiety[MeSHID:D001007] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperuricemia[MeSHID:D033461] |
NA | experimental | inhibitor |
tofisopam | phosphodiesterase 10a | NA | Clinical trial target | TTD | Anxiety Disorders[MeSHID:D001008] Anxiety[MeSHID:D001007] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperuricemia[MeSHID:D033461] |
NA | phase 2 | unknown |
tofisopam | phosphodiesterase 2a | NA | Clinical trial target | TTD | Anxiety Disorders[MeSHID:D001008] Anxiety[MeSHID:D001007] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperuricemia[MeSHID:D033461] |
NA | phase 2 | unknown |
tofisopam | cgmp-dependent 3',5'-cyclic phosphodiesterase | small molecule | NA | drugbank | Anxiety Disorders[MeSHID:D001008] Anxiety[MeSHID:D001007] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperuricemia[MeSHID:D033461] |
NA | experimental | inhibitor |
tofisopam | cgmp-inhibited 3',5'-cyclic phosphodiesterase a | small molecule | NA | drugbank | Anxiety Disorders[MeSHID:D001008] Anxiety[MeSHID:D001007] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperuricemia[MeSHID:D033461] |
NA | experimental | inhibitor |
tofisopam | camp-specific 3',5'-cyclic phosphodiesterase 4a | small molecule | NA | drugbank | Anxiety Disorders[MeSHID:D001008] Anxiety[MeSHID:D001007] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperuricemia[MeSHID:D033461] |
NA | experimental | inhibitor |
tofisopam | phosphodiesterase 4a | NA | Successful target | TTD | Anxiety Disorders[MeSHID:D001008] Anxiety[MeSHID:D001007] Irritable Bowel Syndrome[MeSHID:D043183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperuricemia[MeSHID:D033461] |
NA | phase 2 | unknown |
click here to return to the previous page |